SEC Form 4
| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
|
| OMB APPROVAL |
| OMB Number: |
3235-0287 |
| Estimated average burden |
| hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
|
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. |
1. Name and Address of Reporting Person*
| C/O ROCKWELL MEDICAL, INC. |
| 30142 WIXOM ROAD |
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC.
[ RMTI ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| X |
Director |
|
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
|
|
|
3. Date of Earliest Transaction
(Month/Day/Year)
05/21/2024
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
| X |
Form filed by One Reporting Person |
|
Form filed by More than One Reporting Person |
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
|---|
| 1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
Amount |
(A) or (D) |
Price |
| Common Stock |
05/21/2024 |
|
A
|
|
36,111 |
A |
$0
|
92,062
|
D |
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
|
|---|
| 1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
| Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
| Explanation of Responses: |
|
|
| Remarks: |
|
|
/s/ Megan Timmins, Attorney-in-Fact for Andrea Heslin Smiley |
05/23/2024 |
|
** Signature of Reporting Person |
Date |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
| * If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 24
POWER OF ATTORNEY
Know all by these presents, that, for
good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the undersigned hereby constitutes and
appoints each of Mark Strobeck, Ph.D., Megan Timmins and Ryan Murr, and any of their substitutes, signing singly, the undersigned’s
true and lawful attorney-in-fact to:
(1) execute for and on behalf
of the undersigned (in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the
“Exchange Act”)), any and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary or advisable for the undersigned
to file under Section 16(a) (collectively, “Documents”) with respect to the undersigned’s holdings of and transactions
in the securities issued by Rockwell Medical, Inc., a Delaware corporation (the “Company”).
(2) do and perform any and all
acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Documents and timely file
such Documents with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any
type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each
such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper
to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact
(or such attorney-in-fact’s substitute or substitutes) shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned acknowledges that each attorney-in-fact, in serving in such capacity at the
request of the undersigned, is not assuming, nor is such attorney-in-fact’s substitute or substitutes or the Company assuming, any
of the undersigned’s responsibilities to comply with the Exchange Act.
The undersigned agrees that such attorney-in-fact
may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees
to indemnify and hold harmless the Company and such attorney-in-fact against any losses, claims, damages or liabilities (or actions in
these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the
undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Documents and agrees to reimburse
the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending
against any such loss, claim, damage, liability or action.
This Power of Attorney
shall remain in full force and effect until the undersigned is no longer required to file Documents with respect to the undersigned’s
holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered
to each of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to be executed as of this 1st day of February, 2024.
| |
/s/ Andrea Heslin Smiley |
| |
Name: Andrea Heslin Smiley |
Exhibit 24
POWER OF ATTORNEY
Know all by these presents, that, for
good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the undersigned hereby constitutes and
appoints each of Mark Strobeck, Ph.D., Megan Timmins and Ryan Murr, and any of their substitutes, signing singly, the undersigned’s
true and lawful attorney-in-fact to:
(1) execute for and on behalf
of the undersigned (in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (the
“Exchange Act”)), any and all Forms 3, 4 and/or 5, and any amendments thereto, that are necessary or advisable for the undersigned
to file under Section 16(a) (collectively, “Documents”) with respect to the undersigned’s holdings of and transactions
in the securities issued by Rockwell Medical, Inc., a Delaware corporation (the “Company”).
(2) do and perform any and all
acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Documents and timely file
such Documents with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any
type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each
such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper
to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that each such attorney-in-fact
(or such attorney-in-fact’s substitute or substitutes) shall lawfully do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned acknowledges that each attorney-in-fact, in serving in such capacity at the
request of the undersigned, is not assuming, nor is such attorney-in-fact’s substitute or substitutes or the Company assuming, any
of the undersigned’s responsibilities to comply with the Exchange Act.
The undersigned agrees that such attorney-in-fact
may rely entirely on information furnished orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees
to indemnify and hold harmless the Company and such attorney-in-fact against any losses, claims, damages or liabilities (or actions in
these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the
undersigned to such attorney-in-fact for purposes of executing, acknowledging, delivering and filing Documents and agrees to reimburse
the Company and such attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating or defending
against any such loss, claim, damage, liability or action.
This Power of Attorney
shall remain in full force and effect until the undersigned is no longer required to file Documents with respect to the undersigned’s
holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered
to each of the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to be executed as of this 1st day of February, 2024.
| |
/s/ Andrea Heslin Smiley |
| |
Name: Andrea Heslin Smiley |
Grafico Azioni Rockwell Medical (NASDAQ:RMTI)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Rockwell Medical (NASDAQ:RMTI)
Storico
Da Dic 2023 a Dic 2024
